Skip to main content

Table 5 Comparisons of TNF between curcumin supplement and placebo

From: Effect of curcumin supplement or placebo in delayed onset muscle soreness: a systematic review and meta-analysis

Author Curcumin Placebo
N Mean SD N Mean SD
(a) TNF preexercise
Nicol LM 17  − 0.5 0 17  − 0.5 0
Tanabe Y 14 1.83 0.7 14 1.62 0.28
McFarlin BK 14 3.73 0.22 14 3.87 0.37
Basham SA 20 1.17 0.1 20 1.12 0.04
Tanabe Y (pre) 10 0.63 0.18 10 0.63 0.17
Tanabe Y (post) 10 0.59 0.16 10 0.58 0.18
Mallard AR 13 8 5.5 14 5.5 3.7
UMD (95% CI)     0.04 (− 0.00, 0.08)   
(b) TNF post-exercise
Nicol LM 17 2.5 2.5 17 2.8 8
Tanabe Y 14 1.55 0.42 14 1.97 1.55
Basham SA 20 1.14 0.1 20 1.09 0.04
Tanabe Y (pre) 10 0.61 0.19 10 0.61 0.19
Tanabe Y (post) 10 0.59 0.11 10 0.62 0.09
Mallard AR 13 7.5 3.4 14 3.4 3.1
UMD (95%CI)     0.01 (− 0.11, 0.13)   
(c) TNF at 24 h
Nicol LM 17 1.5 1.4 17 2 4
Tanabe Y 14 1.62 0.35 14 1.83 0.35
McFarlin BK 14 3.58 0.22 14 4.75 0.37
Basham SA 20 0.1 0.1 20 0.96 0.04
Tanabe Y (pre) 10 0.58 0.19 10 0.56 0.14
Tanabe Y (post) 10 0.16 0.54 10 0.55 0.17
Mallard AR 13 8.4 4.1 14 4.1 2.6
UMD (95%CI)      − 0.40 (− 0.85, 0.06)   
(d) TNF at 48 h
Nicol LM 17 3.5 0.5 17 0.8 2.66
Tanabe Y 14 2.04 0.77 14 2.18 1.48
McFarlin BK 14 3.73 0.22 14 4.75 0.37
Basham SA 20 1.08 0.1 20 1.07 0.07
Mallard AR 13 7.2 3.5 14 3.5 1.9
UMD (95%CI)     0.49 (− 0.33, 1.30)   
(e) TNF at 72 h
Tanabe Y 14 1.83 0.28 14 1.76 0.28
McFarlin BK 14 3.73 0.22 14 4.6 0.37
Tanabe Y (pre) 10 0.58 0.18 10 0.56 0.15
Tanabe Y (post) 10 0.59 0.13 10 0.58 0.17
Mallard AR 13 7.4 3.5 14 3.5 2.3
UMD (95%CI)      − 0.08 (− 0.47, 0.31)   
(f) TNF at 96 h
Tanabe Y 14 1.83 0.28 14 1.83 0.28
McFarlin BK 14 3.65 0.22 14 4.68 0.44
UMD (95%CI)      − 0.51 (− 1.52, 0.50)